ResMed Inc. (ASX:RMD)
Australia · Delayed Price · Currency is AUD 37.92
+0.46 (1.23%)
At close: Feb 6, 2026
ResMed Market Cap
ResMed has a market cap or net worth of 56.45 billion as of February 6, 2026. Its market cap has decreased by -3.03% in one year.
Market Cap
56.45B
Enterprise Value
55.64B
Revenue
8.09B
Ranking
n/a
PE Ratio
25.34
Stock Price
37.92
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 53.86M to 56.45B, an increase of 104,699.20%. That is a compound annual growth rate of 25.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 56.45B | 7.25% |
| Dec 31, 2025 | 52.63B | -3.01% |
| Dec 31, 2024 | 54.27B | 46.20% |
| Dec 29, 2023 | 37.12B | -17.49% |
| Dec 30, 2022 | 44.98B | -14.11% |
| Dec 31, 2021 | 52.37B | 31.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 87.01B |
| Pro Medicus | 16.47B |
| Cochlear | 16.36B |
| Sonic Healthcare | 10.88B |
| Ramsay Health Care | 8.25B |
| Ansell | 4.50B |
| Telix Pharmaceuticals | 3.34B |
| Mesoblast | 2.88B |